Momenta Pharmaceuticals v. Teva Pharmaceuticals USA

Goodwin attorneys achieved a significant victory for our client on the scope of infringement under 35 U.S.C. § 271(g) for products made overseas using a patented process. The Federal Circuit held that a manufacturer does not infringe under Section 271(g) merely by using a patented process in order to analyze a product where the product was not actually “made” using that process.

Momenta Pharmaceuticals v. Teva Pharmaceuticals USA

Download PDF

Leave a reply

Your email address will not be published. Required fields are marked *